Cambridge Clinical Laboratories Ltd
05382262
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 26/02/2026
Due 12/03/2027
Industry
Officers
director · Since 10/04/2025
DIRECTOR
BRITISH · ENGLAND · Age 52
Also on 14 other boards
Persons with Significant Control
Source Genomics Limited
1 Orchard Place, Nottingham Business Park, Nottingham, NG8 6PX
Reg: 14552442 · England And Wales · Private Limited Company
Notified 10/04/2025
Former PSCs
Novacyt S.A
Ceased 18/07/2019
Cambridge Pathology B.V.
Ceased 10/04/2025
Charges0 outstanding
KREOS CAPITAL V (UK) LIMITED (THE "CHARGEE")
ROBERT POWELL (AS SECURITY TRUSTEE)
KREOS CAPITAL IV (UK) LIMITED (THE LENDER)
CLYDESDALE BANK PLC
CLYDESDALE BANK PLC (TRADING AS BOTH CLYDESDALE BANK AND YORKSHIRE BANK)
CLYDESDALE BANK PLC (THE "SECURED PARTY")
KREOS CAPITAL III (UK) LIMITED
ANTHONY CLAY, GARY CARLYLE, HAMISH WILLIAMS, JONATHAN BEATSON-HIRD, JONATHAN COWAN,JONATHAN LAU
MICHAEL JOHN FOWLER AND METELLA FOWLER
MICHAEL JOHN FOWLER AND METELLA FOWLER
KREOS CAPITAL III (UK) LIMITED
PETER NIGEL APPLETON AS SECURITY TRUSTEE FOR AND ON BEHALF OF PETER APPLETON ROBERT BROWNEMENT · PETER NIGEL APPLETON AS SECURITY TRUSTEE FOR AND ON BEHALF OF PETER APPLETON ROBERT BROWNESTEES · PETER NIGEL APPLETON AS SECURITY TRUSTEE FOR AND ON BEHALF OF PETER APPLETON ROBERT BROWNECOLIN
CITY ESTATES LIMITED
MERLIN GENERAL PARTNER III LIMITED AND MERLIN BIOSCIENCES GENERAL PARTNER III GMBH
CompanyRankvs 34828+ SIC 74909 peers51
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
-£1.4M
Balance sheet strength
Cash
£1k
Cash in the bank
Net Current Assets
-£162k
Working capital
Current Assets
£302k
Current Liabilities
£464k
Fixed Assets
£90k
Debtors
£251k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.65 | -£712k |
| 2023 | 1.10 | -£609k |
| 2022 | 1.71 | -£594k |
| 2021 | 2.14 | +£410k |
| 2020 | 2.14 | +£207k |
| 2019 | 0.58 | — |
Derived from filed accounts. Not audited figures.